What Biotech CEOs (and Their Funders) Learned From the Theranos Debacle Nonso Jr. August 02, 2017 A+ A- Print Email Biotech investors are still stunned by the rise and fall of the one-drop blood testing startup. But they're hellbent on making sure they don’t all get burned again. via Tingle Tech Labels: Feed: All Latest, Tingle Tech